Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
COVID; COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 71-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "slightly anemic" (not ongoing); "used to be a smoker" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, start date: 2025. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 24Jun2025, outcome "recovering" and all described as "COVID". Clinical course: The patient had been diagnosed with COVID on 24Jun2025 and stated that about 3 to 5 years ago took the vaccinations with the booster. The patient had gotten better. On 24Jun2025 was probably the worst day, was miserable on 23Jun2025 night and 24Jun2025. He was doing better on 25Jun2025. The patient took within the last couple of days codeine, Tylenol and a nasal spray called fluticasone propionate with no issue. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500129432 Same Pt/Vaccine, Diff Dose/AE;
Medical History/Concurrent Conditions: Anemic; Ex-smoker